Clinical outcomes of CyberKnife stereotactic body radiotherapy for peripheral stage I non-small cell lung cancer

scientific article

Clinical outcomes of CyberKnife stereotactic body radiotherapy for peripheral stage I non-small cell lung cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S12032-015-0506-1
P932PMC publication ID4312559
P698PubMed publication ID25638468
P5875ResearchGate publication ID271708150

P2093author name stringBing Li
Xi-Xu Zhu
Xin-Hu Wu
Ze-Tian Shen
P2860cites workAccuracy of tumor motion compensation algorithm from a robotic respiratory tracking system: a simulation study.Q50735226
Prognosis and survival in resected lung carcinoma based on the new international staging systemQ69835930
Radiation therapy alone for stage I non-small cell lung cancerQ72569985
Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planningQ73174029
[Feasibility and efficacy of cyberknife radiotherapy for lung cancer: early results]Q81790688
Treatment of early non-small cell lung cancer, stage IA, by image-guided robotic stereotactic radioablation--CyberKnifeQ95779507
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)Q28131668
Stereotactic radiotherapy with real-time tumor tracking for non-small cell lung cancer: clinical outcomeQ33419548
Stereotactic body radiation therapy for inoperable early stage lung cancerQ34010065
Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancerQ34575077
Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study GroupQ34721402
Radical stereotactic radiosurgery with real-time tumor motion tracking in the treatment of small peripheral lung tumorsQ36326883
Cancer as a manifestation of aberrant chromatin structureQ36651427
Robotic whole body stereotactic radiosurgery: clinical advantages of the Cyberknife integrated systemQ36828679
CyberKnife radiosurgery for stage I lung cancer: results at 36 monthsQ36965063
Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysisQ38021143
Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experienceQ41677591
Measurements of the relative output factors for CyberKnife collimatorsQ46085024
Stereotactic radiosurgery for lung tumors: preliminary report of a phase I trialQ46254774
Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancerQ48151239
Early results of CyberKnife image-guided robotic stereotactic radiosurgery for treatment of lung tumorsQ48898583
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue3
P304page(s)55
P577publication date2015-02-01
P1433published inMedical OncologyQ2152666
P1476titleClinical outcomes of CyberKnife stereotactic body radiotherapy for peripheral stage I non-small cell lung cancer
P478volume32

Reverse relations

cites work (P2860)
Q47877896A phase I/II study on stereotactic body radiotherapy with real-time tumor tracking using CyberKnife based on the Monte Carlo algorithm for lung tumors
Q38663392Clinical Outcomes of 130 Patients with Primary and Secondary Lung Tumors treated with Cyberknife Robotic Stereotactic Body Radiotherapy
Q37691881Clinical outcomes of CyberKnife stereotactic radiosurgery for elderly patients with presumed primary stage I lung cancer
Q37109928Comparing the clinical outcomes in stereotactic body radiotherapy for lung tumors between Ray-Tracing and Monte-Carlo algorithms
Q36382039Comparison of particle beam therapy and stereotactic body radiotherapy for early stage non-small cell lung cancer: A systematic review and hypothesis-generating meta-analysis
Q40496623Dosimetric factors predicting radiation pneumonitis after CyberKnife stereotactic body radiotherapy for peripheral lung cancer
Q58584561Treatment-Related Adverse Effects in Lung Cancer Patients after Stereotactic Ablative Radiation Therapy

Search more.